Statistics for Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer

Total visits

views
Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer 176

Total visits per month

views
October 2024 0
November 2024 0
December 2024 0
January 2025 0
February 2025 0
March 2025 0
April 2025 0

File Visits

views
41467_2018_Article_7264.pdf 156
java.util.UUID:b9ce7e27-68e1-4c7e-9125-b0ca148abe79 38
java.util.UUID:c038f78c-7e60-4b83-9443-c6b7e3784b6e 16
java.util.UUID:1144bcfc-e95f-4287-abec-63a98854e3cb 5

Top country views

views
United States 133
Germany 7
Ukraine 5
Canada 3
United Kingdom 3
China 1
Greece 1
Iran 1
Italy 1
Malaysia 1
Russia 1
Sweden 1
Vietnam 1

Top city views

views
Wilmington 46
Fairfield 18
Houston 14
San Francisco 7
Jacksonville 6
Kiev 5
Kiez 5
Ann Arbor 4
Baltimore 4
Cambridge 4
Toronto 3
Gunzenhausen 2
Athens 1
Beijing 1
Bloomington 1
Bolzano 1
Brooklyn 1
Chevy Chase 1
Hanoi 1
Monmouth Junction 1
Scottsdale 1
Seremban 1
Stockholm 1
Tehran 1
Zheleznogorsk 1